BETAAccess all features while we're in beta! Some features may become paid later.Send feedback →
vpside

GH

Guardant Health, Inc.
Nasdaq · Services · Medical laboratories (SIC 8071) · FY ends 31 Dec

Revenue, quarterly

$335M+44.3% year on year
$400M$200M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 30 Jul 2026 · Q4 = FY − 9Mvpside.com

Gross margin, trailing twelve months

65.0%+2.2 pp year on year
66%64%62%60%
Q4 ’24Q2 ’25Q3 ’25Q1 ’26Q2 ’26
Company filings · 10-Q filed 30 Jul 2026 · TTM = last four quartersvpside.com

Cash and cash equivalents, quarter-end

$1.05B+67.4% year on year
$1.5B$1B$500M$0
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 30 Jul 2026 · balance sheet, period-endvpside.com

Free cash flow, trailing twelve months

−$241M
$200M$0−$200M−$400M−$600M
Q3 ’21Q4 ’22Q1 ’24Q1 ’25Q2 ’26
Company filings · 10-Q filed 30 Jul 2026 · TTM = last four quartersvpside.com
Chart 05 is empty
Chart 06 is empty